as on
| Source : NSE
as on August 26, 2025 at 4:01 pm IST
Day's Low
Day's High
0.80%
Downside
2.00%
Upside
52 Week's Low
52 Week's High
31.96%
Downside
18.61%
Upside
Market Stats | |
Previous Close | ₹827.60 |
Open | ₹830.65 |
Volume | 4.04L |
Upper Circuit | ₹993.10 |
Lower Circuit | ₹662.10 |
Day's Low | ₹812.1 |
Day's High | ₹835 |
52 Week Low | ₹557.05 |
52 Week High | ₹971 |
Returns % | |
1 Month Return | -11.3 % |
3 Month Return | -7.03 % |
1 Year Return | + 24.92 % |
3 Year Return | + 184.01 % |
5 Year Return | + 184.01 % |
Check Aarti Pharmalabs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹7,419.80 Cr
Return on Equity (ROE)
13.11
PE Ratio (TTM)
27.85
Return on capital employed (ROCE)
16.4
Industry PE ratio
43.96
Beta (LTM)
0.91
P/B Ratio
2.43
Dividend Yield
0.69
PEG Ratio
6.13
Quarterly Earnings Growth YOY
-10.73
EPS (TTM)
23.93
Sector
Pharmaceuticals
Book Value
193.88
Technical Analysis
Bearish
View Technical Analysis
Track how Aarti Pharmalabs Ltd P/E has moved over time to understand its valuation trends.
Aarti Pharmalabs Ltd in the last 5 years
Lowest (11.23x)
February 2, 2023
Today (27.85x)
August 26, 2025
Industry (43.96x)
August 26, 2025
Highest (32.82x)
July 16, 2025
Today’s Price to Earnings Ratio: 27.85x
Get the annual and quarterly financial summary of Aarti Pharmalabs Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Aarti Pharmalabs Ltd.
Aarti Pharmalabs Ltd’s net profit fell -10.73% since last year same period to ₹49.50Cr in the Q1 2025-2026. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated -43.97% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending December 2024, Aarti Pharmalabs Ltd has declared dividend of ₹2.50 per share on 05 Feb 2025 - translating a dividend yield of 0.67%.
Read More about DividendsCheck stock indices that include Aarti Pharmalabs Ltd.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Aarti Pharmalabs Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 43.72% | ||
Foreign Institutions | 7.35% | ||
Mutual Funds | 0.9% | 15.04 | |
Retail Investors | 41.12% | 0.77 | |
Others | 6.9% | 2.12 |
Compare market cap, revenue, PE, and other key metrics of Aarti Pharmalabs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 7,419.80 | 36.8% | 0.57 | 216 | 1,852 | |
NA | 8.81 | 39.65% | 0.00 | -1 | 1 | |
NA | 31.22 | -5.34% | 0.00 | 1 | 150 | |
NA | 3,779.96 | 64.71% | 0.70 | 86 | 806 | |
HOLD | 31,756.80 | 1.19% | 0.53 | 698 | 5,616 |
Latest news and events in one place to help you make informed investing decisions in Aarti Pharmalabs Ltd.
Aarti Pharmalabs Reports Decline in Profit - 13 Aug, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 40.81% to 41.12% in Jun 2025 quarter
MF Holding Up
Mutual Funds have increased holdings from 0.78% to 0.90% in Jun 2025 quarter
Promoter Holding Down
Promoters have decreased holdings from 44.29% to 43.72% in Jun 2025 quarter
Price Dip
In the last 1 month, AARTIPHARM stock has moved down by -11.3%
Profit Down
Netprofit is down for the last 2 quarters, 88.34 Cr → 49.5 Cr (in ₹), with an average decrease of 44.0% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 7.36% to 7.35% in Jun 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 562.17 Cr → 387.79 Cr (in ₹), with an average decrease of 31.0% per quarter
Organisation | Aarti Pharmalabs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | Rashesh C Gogri |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Aarti Pharmalabs Ltd.
Aarti Pharmalabs Ltd share price today stands at ₹818.65, Open: ₹830.65, Previous Close: ₹827.6, High: ₹835, Low: ₹812.1, 52 Week High: ₹971, 52 Week Low: ₹557.05 as on .
To buy Aarti Pharmalabs Ltd shares, you need to follow these steps:
Today's traded volume of Aarti Pharmalabs Ltd is 4.04L. Which means that 4.04L shares of Aarti Pharmalabs Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Aarti Pharmalabs Ltd is ₹7,419.80 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Aarti Pharmalabs Ltd’s 52 week high is ₹971 and 52 week low is ₹557.05. The current share price of Aarti Pharmalabs Ltd is ₹818.65, which is -15.69% down from its 52 week high and 46.96% up from its 52 week low.